Real-time PCR assays for the detection of Mycoplasma hyopneumoniae in clinical samples

Two real-time PCR assays for detection of Mycolasma hyopneumoniae (Mhyop) in clinical lung samples were established and validated in parallel. One is targeting a repetitive DNA element (REP assay) the other a putative ABC transporter gene (ABC assay). The two assays were shown to be 100% specific when testing pig lungs from defined negative farms. When investigating defined positive farms the REP assay tested with a sensitivity of about 50%, the ABC assay with 90%. The two assays together, however detected 100% of positive farms. Within a single positive farm on average 90% of the samples tested positive with the REP or ABC assay. Analysing a set of 41 lungs from infected pigs from routine diagnostic the REP assay detected 50% and the ABC assay 70%, while both assays together had a sensitivity of 85%

Air Quality Modelling and Source Apportionment Studies for Aerosols in Switzerland

We modelled the air quality in Switzerland for summer and winter periods in 2006 using the CAMx model with the focus on aerosols. The contributions of various source regions to aerosol concentrations at receptor sites were investigated using the Particulate Matter Source Apportionment Technology (PSAT) tool of CAMx. The source regions were defined as Switzerland, surrounding countries and other countries in Europe. Organic aerosols (OA) and particulate nitrate (PNO3) are the main components of winter aerosols in the modeled domain. In summer, organic aerosols dominate the aerosol composition and they are mainly secondary. In general more than 50% of PM2.5 was predicted to come from Swiss sources except for a few sites at the border regions. Primary particles originate mostly from local sources in both seasons, except at Basel where significant contribution from France and Germany was predicted. In the south, Italy is the main contributor to aerosols. On the other hand, about half of the secondary aerosols originate from Germany and France for receptors in the north and from Italy for receptors in the south

Passive motion of the lower extremities in sedated and ventilated patients in the ICU - a systematic review of early effects and replicability of Interventions.

Early mobilization, which includes active / passive motion in bed along with mobilization out of bed, is recommended to prevent the development of intensive care unit acquired-weakness (ICU-AW) for patients with critical illness on the intensive care unit. To date, the impact of passive motion of the lower extremities in sedated and ventilated patients remains unclear. The aim of the study is to systematically review and summarize the currently available randomized controlled trials in English or German language on the impact of passive motion of the lower extremities in sedated and ventilated patients ≥ 18 years in the intensive care unit on musculature, inflammation and immune system and the development of intensive care unit-acquired weakness and to evaluate the replicability of interventions and the methodological quality of included studies. A systematic literature search was performed up to 20th February 2022 in the databases Medline, Embase, Cochrane Library, CINAHL and PEDro. The description of the intervention (TIDieR checklist) and the methodological quality (Downs and Black checklist) were assessed. Five studies were included in the qualitative syntheses. On average, the studies were rated with 6.8 out of 12 points according to the TIDieR checklist. For the methodological quality an average of 19.8 out of 27 points on the Downs and Black checklist was reported. The results of included studies indicated that muscle loss may be reduced by passive manual movement, passive cycling and passive motion on a continuous passive motion-unit. In addition, positive effects were reported on the reduction of nitrosative stress and the immune response. The impact on the development of ICU-AW remains unclear. In conclusion, passive movement show a slight tendency for beneficial changes on cellular level in sedated and ventilated patients in the ICU within the first days of admission, which may indicate a reduction of muscle wasting and could prevent the development of ICU-AW. Future randomized controlled trials should use larger samples, use complete intervention description, use a comparable set of outcome measures, use rigorous methodology and examine the effect of passive motion on the development of ICU-AW

Real-time PCR assays for the detection of Mycoplasma hyopneumoniae in clinical samples

Two real-time PCR assays for detection of Mycolasma hyopneumoniae (Mhyop) in clinical lung samples were established and validated in parallel. One is targeting a repetitive DNA element (REP assay) the other a putative ABC transporter gene (ABC assay). The two assays were shown to be 100% specific when testing pig lungs from defined negative farms. When investigating defined positive farms the REP assay tested with a sensitivity of about 50%, the ABC assay with 90%. The two assays together, however detected 100% of positive farms. Within a single positive farm on average 90% of the samples tested positive with the REP or ABC assay. Analysing a set of 41 lungs from infected pigs from routine diagnostic the REP assay detected 50% and the ABC assay 70%, while both assays together had a sensitivity of 85%.</p